Indraprastha Medical Corporation Limited (INDRAMEDCO) Stock Statistics & Valuation Metrics

Indraprastha Medical Corporation Limited has a market cap or net worth of ₹42.11B. The enterprise value is ₹36.37B.

Indraprastha Medical Corporation Limited has 91,673,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Indraprastha Medical Corporation Limited’s return on equity (ROE) is 0.27 and return on invested capital (ROIC) is 54.41%.

The current PE Ratio of Indraprastha Medical Corporation Limited is 25.1. Indraprastha Medical Corporation Limited’s PEG ratio is ―.

In the last 12 months, Indraprastha Medical Corporation Limited had revenue of 13.56B and earned 1.61B in profits. Earnings per share was 17.56.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Indraprastha Medical Corporation Limited pays an annual dividend of ₹4.5, resulting in a dividend yield of 0.98%

Indraprastha Medical Corporation Limited upcoming earnings date is Oct 31, 2025, TBA (Confirmed).

Indraprastha Medical Corporation Limited as a current ratio of 2.41, with Debt / Equity ratio of 5.49%

In the past 12 months, Indraprastha Medical Corporation Limited has paid 553.30M in taxes.

Indraprastha Medical Corporation Limited EV to EBITDA ratio is 13.57, with an EV/FCF ratio of 27.52.

Indraprastha Medical Corporation Limited has ₹3.22B in cash and marketable securities with ₹327.60M in debt, giving a net cash position of -₹2.89B billion.

Gross margin is 35.69%, with operating margin of 36.39%, and net profit margin of 11.87%.

The average price target for Indraprastha Medical Corporation Limited is ₹489.00, which is 11.43% higher than the current price. The consensus rating is Hold